Weight changes are one of the most common concerns people have when starting an antidepressant, and for good reason — some antidepressants, particularly certain tricyclic antidepressants, monoamine oxidase inhibitors (MAOIs), mirtazapine, and some SSRIs, have been associated with weight gain in some people.
If you’ve been prescribed Cymbalta (duloxetine) or are considering it, you may be wondering how it will affect your weight. While individual responses may vary, the research is reassuring: Cymbalta is more likely to cause slight weight loss in the short term and modest weight gain with longer use. For many people, the overall effect on weight is relatively small.
Understanding the nuances of how Cymbalta affects weight, including what happens in the short term versus the long term and how it compares to other antidepressants, can help set realistic expectations and empower you to manage any changes proactively.
Key Takeaways
The relationship between antidepressants and weight gain is often complex. In short-term clinical trials, duloxetine-treated patients lost an average of about 0.5 kg (roughly 1 pound) during the first 8-9 weeks compared to a slight gain with placebo. This early weight loss may be related in part to nausea and reduced appetite, which are common side effects during the first weeks of treatment.
Over longer-term use (up to 52 weeks), patients experienced a modest average weight gain of about 1.1 kg (roughly 2.4 pounds). Recent studies indicate patients on duloxetine were 10-15% more likely to gain at least 5% of baseline weight over a six-month period, although weight gain could plateau at 12-18 months.
For most people, this is a relatively small change that can often be managed with lifestyle strategies like regular exercise and balanced nutrition. If you notice significant or distressing weight changes while taking Cymbalta, talk to your provider early. They can discuss dose adjustments or alternative medications if needed.
What is Cymbalta, and How Does it Affect Weight?
Cymbalta, a brand name for the drug duloxetine, is a serotonin and norepinephrine reuptake inhibitor (SNRI) antidepressant that is FDA-approved for treating major depressive disorder (MDD), generalized anxiety disorder (GAD), and other conditions, including diabetic neuropathic pain and fibromyalgia.
Some antidepressants are more often associated with weight gain than others, including tricyclic antidepressants (amitriptyline and nortriptyline), mirtazapine and MAOIs. Another antidepressant, bupropion, is more often associated with weight loss in patients.
In the case of Cymbalta, several factors can influence its impact on weight. Dosage, duration of treatment, genetic factors, lifestyle, and baseline BMI have a role to play in how individuals respond.
Analyses of clinical trials from 1999-2003 revealed minimal short-term and long-term effects on weight for many patients on duloxetine.
However, in a recent observational study comparing several first-line antidepressants, duloxetine was associated with a higher risk for modest weight gain compared to sertraline (Zoloft).
What the Research Shows: Short-Term Effects
An analysis of all 10 phase II and III clinical studies of duloxetine for major depressive disorder examined body weight data comprehensively. During the first 8 to 9 weeks of acute treatment, patients on duloxetine lost an average of 1.1 pounds, while those on placebo gained around 0.4 pounds. This was a statistically significant difference, and there was no consistent relationship between the duloxetine dose and the amount of weight change.
Another interesting finding from the trials was that a higher BMI was associated with greater weight loss on duloxetine than on placebo. While a BMI less than 25 resulted in an average weight loss of around 0.4 pounds on duloxetine vs an average gain of 0.7 pounds on placebo, patients with a BMI of 30 or above experienced an average weight loss of approximately 2 pounds on duloxetine vs an average gain of 0.9 pounds on placebo.
When compared directly to other antidepressants in the same trials, duloxetine produced similar short-term weight changes to fluoxetine (1.5 pounds vs 1.3 pounds weight loss) and paroxetine (0.6 pounds vs 0.4 pounds weight loss). This meant that duloxetine wasn’t noticeably better or worse than common alternatives in the early weeks.
The initial weight loss is thought to be related to nausea and decreased appetite, which are among the most common early side effects of Cymbalta. As these side effects resolve over the first few weeks, appetite typically returns to normal.
What the Research Shows: Long-Term Effects
The weight picture shifts modestly with longer-term use. During 34 weeks of treatment, patients on the higher dose of duloxetine (120 mg daily) gained about 2 pounds, which was significantly more than placebo (0.2 pounds) but still relatively modest. In a 52-week open-label study that was a part of the same trial, the average weight gain was 2.4 pounds.
A separate analysis of 16 clinical studies examining weight changes in patients taking duloxetine for chronic pain conditions (diabetic neuropathy, fibromyalgia, and chronic low back pain) found consistent results.
Patients with fibromyalgia and chronic low back pain showed modest weight increases (up to 2.4 pounds over extended treatment periods, while patients with diabetic neuropathy actually showed overall weight loss (up to 3.7 pounds) at endpoint.
The results indicate that long-term duloxetine use was associated with modest weight gain in many patients.
How Does Cymbalta Compare to Other Antidepressants?
A large observational study recently published in Annals of Internal Medicine tracked weight changes across more than 183,000 patients starting common first-line antidepressants. Using sertraline (Zoloft) as the reference point, the study found that at six months:
More weight gain than sertraline: Escitalopram (+0.9 pounds), paroxetine (+0.8 pounds), duloxetine (+0.7 pounds), venlafaxine (+0.4 pounds), citalopram (+0.3 pounds)
Similar to sertraline: Fluoxetine (-0.15 pounds)
Less weight gain than sertraline: Bupropion (-0.5 pounds), the only antidepressant associated with weight loss relative to other options
The study concluded that patients on duloxetine, along with escitalopram and paroxetine, were 10-15% more likely to gain at least 5% of their baseline weight compared to those on sertraline.
However, the study also indicated that over two years, weight gain was lower for duloxetine and venlafaxine (SNRIs) than sertraline (SSRI), due to a plateauing of weight gain between 12-18 months for SNRI antidepressants.
Notably, in an 8-month comparison trial of duloxetine versus escitalopram (Lexapro), escitalopram was associated with more weight gain (4 pounds) than duloxetine (1.3 pounds) over the study period.
Why Might Weight Change Happen?
Several factors can contribute to weight changes during antidepressant treatment, and understanding them can help you differentiate between medication effects and other influences:
Appetite recovery: Depression and anxiety often suppress appetite. As these conditions improve with treatment, appetite frequently returns to normal — or even increases beyond pre-illness levels. This can lead to weight gain that actually reflects successful treatment rather than a medication side effect.
Reduced nausea: Nausea is the most common early side effect of Cymbalta and naturally suppresses appetite. As nausea resolves, appetite typically rebounds.
Metabolic effects: Serotonergic and noradrenergic medications may have subtle effects on metabolism and body composition, though this isn’t well-established for duloxetine, unlike for medications like mirtazapine or certain antipsychotics.
Activity level changes: Depression often reduces physical activity and motivation to exercise. As symptoms improve, some people become more active (which can help maintain weight), while others may find improved energy leads to more eating without corresponding exercise increases.
Sleep changes: Both depression and its treatment can affect sleep quality, which in turn influences appetite hormones and metabolic function.
Managing Weight While Taking Cymbalta
If weight management is important to you, there are practical steps you can take:
Monitor your weight regularly (about once a week) during the first six to twelve months of treatment to catch any trends early
Focus on balanced nutrition with whole foods, lean proteins, fruits, vegetables, and limited processed foods
Stay physically active: even moderate daily walking of 20 to 30 minutes can make a meaningful difference for both weight management and mood
Be mindful of appetite changes as your mood improves: increased appetite can be a sign of recovery, but it helps to eat mindfully rather than automatically
Discuss concerns with your provider early, before weight changes become significant. They can help determine whether changes are related to the medication, your condition improving, or other factors
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. The information provided should not replace consultation with a qualified healthcare provider. Individual responses to medications can vary significantly, and what applies to one person may not be the same for another.
Always consult with your doctor or pharmacist before making any decisions about medication changes, discontinuation, or interactions with other substances. If you’re experiencing concerning symptoms or side effects, please seek professional help from a healthcare provider.
In case of a medical emergency, contact your local emergency services immediately or call 911. For mental health emergencies, contact the National Suicide Prevention Lifeline at 988.
Sources
Wise, T. N., Perahia, D. G., Pangallo, B. A., Losin, W. G., & Wiltse, C. G. (2006). Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies. Primary care companion to the Journal of clinical psychiatry, 8(5), 269–278. https://pmc.ncbi.nlm.nih.gov/articles/PMC1764530
Gaynor, P., McCarberg, B., Zheng, W., Shoemaker, S., & Duenas, H. (2011). Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies. International journal of clinical practice, 65(3), 341–349. https://pubmed.ncbi.nlm.nih.gov/21314871/
Mouawad, M., Nabipur, L., & Agrawal, D. K. (2025). Impact of Antidepressants on Weight Gain: Underlying Mechanisms and Mitigation Strategies. Archives of clinical and biomedical research, 9(3), 183–195. https://pmc.ncbi.nlm.nih.gov/articles/PMC12121960/
Petimar, J., Young, J. G., Yu, H., Rifas-Shiman, S. L., et al. (2024). Medication-Induced Weight Change Across Common Antidepressant Treatments: A Target Trial Emulation Study. Annals of internal medicine, 177(8), 993–1003. https://pmc.ncbi.nlm.nih.gov/articles/PMC11819980/
U.S. Food and Drug Administration. (2023). Cymbalta (duloxetine delayed-release capsules): Prescribing information.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf
Pigott, T. A., Prakash, A., Arnold, L. M., Aaronson, S. T., Mallinckrodt, C. H., & Wohlreich, M. M. (2007). Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Current medical research and opinion, 23(6), 1303–1318. https://pubmed.ncbi.nlm.nih.gov/17559729/
National Institute of Mental Health. (2023, December). Mental health medications. https://www.nimh.nih.gov/health/topics/mental-health-medications
Mayo Clinic. (2026, February 1). Duloxetine (oral route): Side effects. https://www.mayoclinic.org/drugs-supplements/duloxetine-oral-route/side-effects/drg-20067247
Cleveland Clinic. (n.d.). Antidepressants and weight gain. https://my.clevelandclinic.org/health/drugs/9297-antidepressants-weight-gain
Medical News Today. (2024, January 19). Can taking Cymbalta affect a person's weight? https://www.medicalnewstoday.com/articles/323575
